The Spot sign and Tranexamic acid On Preventing ICH growth – AUStralasia Trial (STOP‐AUST): Protocol of a phase II randomized, placebo‐controlled, double‐blind, multicenter trial

DiscussionThis is the first trial to evaluate the efficacy of tranexamic acid in intracerebral hemorrhage patients selected based on an imaging biomarker of high likelihood of hematoma growth. The trial is registered as NCT01702636.

Source: International Journal of Stroke - August 26, 2013 Category: Neurology Authors: Atte Meretoja, Leonid Churilov, Bruce C. V. Campbell, Richard I. Aviv, Nawaf Yassi, Christen Barras, Peter Mitchell, Bernard Yan, Harshal Nandurkar, Christopher Bladin, Tissa Wijeratne, Neil J. Spratt, Jim Jannes, Jonathan Sturm, Jayantha Rupasinghe, Jorg Tags: Protocols Source Type: research